Internal Medicine · Charlotte, NC
NPI
1194712240
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1021 Morehead Medical Dr, Ste A
Charlotte, NC, 28204
Phone (980) 442-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
561 services
Medicare patients, 2024
336
Average age 75
Drug cost, 2024
$4.1M
902 prescriptions
Company payments, 2025
$110
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jonathan K Levine was code 99213 (office e&m - established), 227 times for 193 patients. In total Jonathan K Levine billed 561 services in 16 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 227 | 193 | $41.03 | $9,313 |
| 99214 Office E&M - Established | Office | 183 | 121 | $64.07 | $12K |
| 99215 Office E&M - Established | Office | 43 | 26 | $102.91 | $4,425 |
| 99204 Office E&M - New | Office | 32 | 32 | $86.81 | $2,778 |
| 99205 Office E&M - New | Office | 11 | 11 | $93.25 | $1,026 |
| 99212 Office E&M - Established | Office | 11 | 11 | $16.41 | $181 |
By year: 2022 $43K for 678 services; 2023 $41K for 652 services; 2024 $33K for 561 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan K Levine prescribed most often to Medicare patients was Eliquis (Apixaban), with 115 prescriptions and refills. In total Jonathan K Levine wrote 902 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 115 | 199 | 25 | $90K |
| Hydroxyurea Generic | 106 | 232 | 23 | $1,761 |
| Xarelto Rivaroxaban | 92 | 167 | 24 | $68K |
| Brukinsa Zanubrutinib | 63 | 63 | 12 | $460K |
| Acyclovir Generic | 59 | 127 | 17 | $1,220 |
| Jakafi Ruxolitinib Phosphate | 56 | 56 | Under 11 | $1.0M |
| Calquence Acalabrutinib Maleate | 49 | 49 | Under 11 | $614K |
| Warfarin Sodium Generic | 39 | 106 | Under 11 | $651 |
| Imbruvica Ibrutinib | 33 | 33 | Under 11 | $529K |
| Oxycodone Hcl Generic | 29 | 29 | Under 11 | $469 |
| Prednisone Generic | 25 | 35 | 11 | $93.62 |
| Ondansetron Hcl Generic | 22 | 22 | Under 11 | $156 |
| Gabapentin Generic | 17 | 17 | Under 11 | $187 |
| Lenalidomide Generic | 16 | 16 | Under 11 | $238K |
| Imatinib Mesylate Generic | 15 | 15 | Under 11 | $85K |
Brand drugs: 469 claims; generic drugs: 433 claims; opioid claims: 41.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jonathan K Levine $110 ($110 in general payments such as food, travel and fees) from 1 company. The largest payer was Genzyme Corporation with $110.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 1 | $110 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.